Recombinant Carbonyl Reductase Industry Research Report 2025

Summary

According to APO Research, the global Recombinant Carbonyl Reductase market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Recombinant Carbonyl Reductase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Recombinant Carbonyl Reductase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Recombinant Carbonyl Reductase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Recombinant Carbonyl Reductase include Abbexa, Abcam, American Research Products, Inc., Biocompare, Biomatik, Cosmo Bio USA, Fisher Scientific, Nordic Diagnostica AB and Novatein Biosciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Carbonyl Reductase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Carbonyl Reductase.

The report will help the Recombinant Carbonyl Reductase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Recombinant Carbonyl Reductase market size, estimations, and forecasts are provided in terms of sales volume (K G) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Carbonyl Reductase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Recombinant Carbonyl Reductase Segment by Company

Abbexa
Abcam
American Research Products, Inc.
Biocompare
Biomatik
Cosmo Bio USA
Fisher Scientific
Nordic Diagnostica AB
Novatein Biosciences
Prospec Bio
RayBiotech
Tebubio
Sino Biological
Cloud-Clone Corp
JUYOU
Recombinant Carbonyl Reductase Segment by Type

Liquid
Powder
Recombinant Carbonyl Reductase Segment by Application

Pharmaceutical Synthesis
Chemical Manufacturing
Others
Recombinant Carbonyl Reductase Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Carbonyl Reductase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Carbonyl Reductase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Carbonyl Reductase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Recombinant Carbonyl Reductase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Recombinant Carbonyl Reductase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Recombinant Carbonyl Reductase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Recombinant Carbonyl Reductase Market Size (2020-2031)
2.2.2 Global Recombinant Carbonyl Reductase Sales (2020-2031)
2.2.3 Global Recombinant Carbonyl Reductase Market Average Price (2020-2031)
2.3 Recombinant Carbonyl Reductase by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Liquid
2.3.3 Powder
2.4 Recombinant Carbonyl Reductase by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Pharmaceutical Synthesis
2.4.3 Chemical Manufacturing
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Recombinant Carbonyl Reductase Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Recombinant Carbonyl Reductase Sales (K G) of Manufacturers (2020-2025)
3.3 Global Recombinant Carbonyl Reductase Revenue of Manufacturers (2020-2025)
3.4 Global Recombinant Carbonyl Reductase Average Price by Manufacturers (2020-2025)
3.5 Global Recombinant Carbonyl Reductase Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Recombinant Carbonyl Reductase, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Recombinant Carbonyl Reductase, Product Type & Application
3.8 Global Manufacturers of Recombinant Carbonyl Reductase, Established Date
3.9 Global Recombinant Carbonyl Reductase Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Abbexa
4.1.1 Abbexa Company Information
4.1.2 Abbexa Business Overview
4.1.3 Abbexa Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Abbexa Recombinant Carbonyl Reductase Product Portfolio
4.1.5 Abbexa Recent Developments
4.2 Abcam
4.2.1 Abcam Company Information
4.2.2 Abcam Business Overview
4.2.3 Abcam Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Abcam Recombinant Carbonyl Reductase Product Portfolio
4.2.5 Abcam Recent Developments
4.3 American Research Products, Inc.
4.3.1 American Research Products, Inc. Company Information
4.3.2 American Research Products, Inc. Business Overview
4.3.3 American Research Products, Inc. Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.3.4 American Research Products, Inc. Recombinant Carbonyl Reductase Product Portfolio
4.3.5 American Research Products, Inc. Recent Developments
4.4 Biocompare
4.4.1 Biocompare Company Information
4.4.2 Biocompare Business Overview
4.4.3 Biocompare Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Biocompare Recombinant Carbonyl Reductase Product Portfolio
4.4.5 Biocompare Recent Developments
4.5 Biomatik
4.5.1 Biomatik Company Information
4.5.2 Biomatik Business Overview
4.5.3 Biomatik Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Biomatik Recombinant Carbonyl Reductase Product Portfolio
4.5.5 Biomatik Recent Developments
4.6 Cosmo Bio USA
4.6.1 Cosmo Bio USA Company Information
4.6.2 Cosmo Bio USA Business Overview
4.6.3 Cosmo Bio USA Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Cosmo Bio USA Recombinant Carbonyl Reductase Product Portfolio
4.6.5 Cosmo Bio USA Recent Developments
4.7 Fisher Scientific
4.7.1 Fisher Scientific Company Information
4.7.2 Fisher Scientific Business Overview
4.7.3 Fisher Scientific Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Fisher Scientific Recombinant Carbonyl Reductase Product Portfolio
4.7.5 Fisher Scientific Recent Developments
4.8 Nordic Diagnostica AB
4.8.1 Nordic Diagnostica AB Company Information
4.8.2 Nordic Diagnostica AB Business Overview
4.8.3 Nordic Diagnostica AB Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Nordic Diagnostica AB Recombinant Carbonyl Reductase Product Portfolio
4.8.5 Nordic Diagnostica AB Recent Developments
4.9 Novatein Biosciences
4.9.1 Novatein Biosciences Company Information
4.9.2 Novatein Biosciences Business Overview
4.9.3 Novatein Biosciences Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Novatein Biosciences Recombinant Carbonyl Reductase Product Portfolio
4.9.5 Novatein Biosciences Recent Developments
4.10 Prospec Bio
4.10.1 Prospec Bio Company Information
4.10.2 Prospec Bio Business Overview
4.10.3 Prospec Bio Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Prospec Bio Recombinant Carbonyl Reductase Product Portfolio
4.10.5 Prospec Bio Recent Developments
4.11 RayBiotech
4.11.1 RayBiotech Company Information
4.11.2 RayBiotech Business Overview
4.11.3 RayBiotech Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.11.4 RayBiotech Recombinant Carbonyl Reductase Product Portfolio
4.11.5 RayBiotech Recent Developments
4.12 Tebubio
4.12.1 Tebubio Company Information
4.12.2 Tebubio Business Overview
4.12.3 Tebubio Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Tebubio Recombinant Carbonyl Reductase Product Portfolio
4.12.5 Tebubio Recent Developments
4.13 Sino Biological
4.13.1 Sino Biological Company Information
4.13.2 Sino Biological Business Overview
4.13.3 Sino Biological Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Sino Biological Recombinant Carbonyl Reductase Product Portfolio
4.13.5 Sino Biological Recent Developments
4.14 Cloud-Clone Corp
4.14.1 Cloud-Clone Corp Company Information
4.14.2 Cloud-Clone Corp Business Overview
4.14.3 Cloud-Clone Corp Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Cloud-Clone Corp Recombinant Carbonyl Reductase Product Portfolio
4.14.5 Cloud-Clone Corp Recent Developments
4.15 JUYOU
4.15.1 JUYOU Company Information
4.15.2 JUYOU Business Overview
4.15.3 JUYOU Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2020-2025)
4.15.4 JUYOU Recombinant Carbonyl Reductase Product Portfolio
4.15.5 JUYOU Recent Developments
5 Global Recombinant Carbonyl Reductase Market Scenario by Region
5.1 Global Recombinant Carbonyl Reductase Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Recombinant Carbonyl Reductase Sales by Region: 2020-2031
5.2.1 Global Recombinant Carbonyl Reductase Sales by Region: 2020-2025
5.2.2 Global Recombinant Carbonyl Reductase Sales by Region: 2026-2031
5.3 Global Recombinant Carbonyl Reductase Revenue by Region: 2020-2031
5.3.1 Global Recombinant Carbonyl Reductase Revenue by Region: 2020-2025
5.3.2 Global Recombinant Carbonyl Reductase Revenue by Region: 2026-2031
5.4 North America Recombinant Carbonyl Reductase Market Facts & Figures by Country
5.4.1 North America Recombinant Carbonyl Reductase Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Recombinant Carbonyl Reductase Sales by Country (2020-2031)
5.4.3 North America Recombinant Carbonyl Reductase Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Recombinant Carbonyl Reductase Market Facts & Figures by Country
5.5.1 Europe Recombinant Carbonyl Reductase Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Recombinant Carbonyl Reductase Sales by Country (2020-2031)
5.5.3 Europe Recombinant Carbonyl Reductase Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Recombinant Carbonyl Reductase Market Facts & Figures by Country
5.6.1 Asia Pacific Recombinant Carbonyl Reductase Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Recombinant Carbonyl Reductase Sales by Country (2020-2031)
5.6.3 Asia Pacific Recombinant Carbonyl Reductase Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Recombinant Carbonyl Reductase Market Facts & Figures by Country
5.7.1 South America Recombinant Carbonyl Reductase Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Recombinant Carbonyl Reductase Sales by Country (2020-2031)
5.7.3 South America Recombinant Carbonyl Reductase Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Recombinant Carbonyl Reductase Market Facts & Figures by Country
5.8.1 Middle East and Africa Recombinant Carbonyl Reductase Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Recombinant Carbonyl Reductase Sales by Country (2020-2031)
5.8.3 Middle East and Africa Recombinant Carbonyl Reductase Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Recombinant Carbonyl Reductase Sales by Type (2020-2031)
6.1.1 Global Recombinant Carbonyl Reductase Sales by Type (2020-2031) & (K G)
6.1.2 Global Recombinant Carbonyl Reductase Sales Market Share by Type (2020-2031)
6.2 Global Recombinant Carbonyl Reductase Revenue by Type (2020-2031)
6.2.1 Global Recombinant Carbonyl Reductase Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Recombinant Carbonyl Reductase Revenue Market Share by Type (2020-2031)
6.3 Global Recombinant Carbonyl Reductase Price by Type (2020-2031)
7 Segment by Application
7.1 Global Recombinant Carbonyl Reductase Sales by Application (2020-2031)
7.1.1 Global Recombinant Carbonyl Reductase Sales by Application (2020-2031) & (K G)
7.1.2 Global Recombinant Carbonyl Reductase Sales Market Share by Application (2020-2031)
7.2 Global Recombinant Carbonyl Reductase Revenue by Application (2020-2031)
7.2.1 Global Recombinant Carbonyl Reductase Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Recombinant Carbonyl Reductase Revenue Market Share by Application (2020-2031)
7.3 Global Recombinant Carbonyl Reductase Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Recombinant Carbonyl Reductase Value Chain Analysis
8.1.1 Recombinant Carbonyl Reductase Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Recombinant Carbonyl Reductase Production Mode & Process
8.2 Recombinant Carbonyl Reductase Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Recombinant Carbonyl Reductase Distributors
8.2.3 Recombinant Carbonyl Reductase Customers
9 Global Recombinant Carbonyl Reductase Analyzing Market Dynamics
9.1 Recombinant Carbonyl Reductase Industry Trends
9.2 Recombinant Carbonyl Reductase Industry Drivers
9.3 Recombinant Carbonyl Reductase Industry Opportunities and Challenges
9.4 Recombinant Carbonyl Reductase Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
Table 5. Global Recombinant Carbonyl Reductase Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
Table 6. Global Recombinant Carbonyl Reductase Sales (K G) of Manufacturers (2020-2025)
Table 7. Global Recombinant Carbonyl Reductase Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Recombinant Carbonyl Reductase Revenue of Manufacturers (2020-2025)
Table 9. Global Recombinant Carbonyl Reductase Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Recombinant Carbonyl Reductase Average Price (US$/K G) of Manufacturers (2020-2025)
Table 11. Global Recombinant Carbonyl Reductase Industry Ranking, 2023 VS 2024 VS 2025
Table 12. Global Manufacturers of Recombinant Carbonyl Reductase, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Recombinant Carbonyl Reductase, Product Type & Application
Table 14. Global Recombinant Carbonyl Reductase Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Recombinant Carbonyl Reductase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Abbexa Company Information
Table 19. Abbexa Business Overview
Table 20. Abbexa Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 21. Abbexa Recombinant Carbonyl Reductase Product Portfolio
Table 22. Abbexa Recent Developments
Table 23. Abcam Company Information
Table 24. Abcam Business Overview
Table 25. Abcam Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 26. Abcam Recombinant Carbonyl Reductase Product Portfolio
Table 27. Abcam Recent Developments
Table 28. American Research Products, Inc. Company Information
Table 29. American Research Products, Inc. Business Overview
Table 30. American Research Products, Inc. Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 31. American Research Products, Inc. Recombinant Carbonyl Reductase Product Portfolio
Table 32. American Research Products, Inc. Recent Developments
Table 33. Biocompare Company Information
Table 34. Biocompare Business Overview
Table 35. Biocompare Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 36. Biocompare Recombinant Carbonyl Reductase Product Portfolio
Table 37. Biocompare Recent Developments
Table 38. Biomatik Company Information
Table 39. Biomatik Business Overview
Table 40. Biomatik Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 41. Biomatik Recombinant Carbonyl Reductase Product Portfolio
Table 42. Biomatik Recent Developments
Table 43. Cosmo Bio USA Company Information
Table 44. Cosmo Bio USA Business Overview
Table 45. Cosmo Bio USA Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 46. Cosmo Bio USA Recombinant Carbonyl Reductase Product Portfolio
Table 47. Cosmo Bio USA Recent Developments
Table 48. Fisher Scientific Company Information
Table 49. Fisher Scientific Business Overview
Table 50. Fisher Scientific Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 51. Fisher Scientific Recombinant Carbonyl Reductase Product Portfolio
Table 52. Fisher Scientific Recent Developments
Table 53. Nordic Diagnostica AB Company Information
Table 54. Nordic Diagnostica AB Business Overview
Table 55. Nordic Diagnostica AB Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 56. Nordic Diagnostica AB Recombinant Carbonyl Reductase Product Portfolio
Table 57. Nordic Diagnostica AB Recent Developments
Table 58. Novatein Biosciences Company Information
Table 59. Novatein Biosciences Business Overview
Table 60. Novatein Biosciences Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 61. Novatein Biosciences Recombinant Carbonyl Reductase Product Portfolio
Table 62. Novatein Biosciences Recent Developments
Table 63. Prospec Bio Company Information
Table 64. Prospec Bio Business Overview
Table 65. Prospec Bio Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 66. Prospec Bio Recombinant Carbonyl Reductase Product Portfolio
Table 67. Prospec Bio Recent Developments
Table 68. RayBiotech Company Information
Table 69. RayBiotech Business Overview
Table 70. RayBiotech Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 71. RayBiotech Recombinant Carbonyl Reductase Product Portfolio
Table 72. RayBiotech Recent Developments
Table 73. Tebubio Company Information
Table 74. Tebubio Business Overview
Table 75. Tebubio Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 76. Tebubio Recombinant Carbonyl Reductase Product Portfolio
Table 77. Tebubio Recent Developments
Table 78. Sino Biological Company Information
Table 79. Sino Biological Business Overview
Table 80. Sino Biological Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 81. Sino Biological Recombinant Carbonyl Reductase Product Portfolio
Table 82. Sino Biological Recent Developments
Table 83. Cloud-Clone Corp Company Information
Table 84. Cloud-Clone Corp Business Overview
Table 85. Cloud-Clone Corp Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 86. Cloud-Clone Corp Recombinant Carbonyl Reductase Product Portfolio
Table 87. Cloud-Clone Corp Recent Developments
Table 88. JUYOU Company Information
Table 89. JUYOU Business Overview
Table 90. JUYOU Recombinant Carbonyl Reductase Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2020-2025)
Table 91. JUYOU Recombinant Carbonyl Reductase Product Portfolio
Table 92. JUYOU Recent Developments
Table 93. Global Recombinant Carbonyl Reductase Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 94. Global Recombinant Carbonyl Reductase Sales by Region (2020-2025) & (K G)
Table 95. Global Recombinant Carbonyl Reductase Sales Market Share by Region (2020-2025)
Table 96. Global Recombinant Carbonyl Reductase Sales by Region (2026-2031) & (K G)
Table 97. Global Recombinant Carbonyl Reductase Sales Market Share by Region (2026-2031)
Table 98. Global Recombinant Carbonyl Reductase Revenue by Region (2020-2025) & (US$ Million)
Table 99. Global Recombinant Carbonyl Reductase Revenue Market Share by Region (2020-2025)
Table 100. Global Recombinant Carbonyl Reductase Revenue by Region (2026-2031) & (US$ Million)
Table 101. Global Recombinant Carbonyl Reductase Revenue Market Share by Region (2026-2031)
Table 102. North America Recombinant Carbonyl Reductase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 103. North America Recombinant Carbonyl Reductase Sales by Country (2020-2025) & (K G)
Table 104. North America Recombinant Carbonyl Reductase Sales by Country (2026-2031) & (K G)
Table 105. North America Recombinant Carbonyl Reductase Revenue by Country (2020-2025) & (US$ Million)
Table 106. North America Recombinant Carbonyl Reductase Revenue by Country (2026-2031) & (US$ Million)
Table 107. Europe Recombinant Carbonyl Reductase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 108. Europe Recombinant Carbonyl Reductase Sales by Country (2020-2025) & (K G)
Table 109. Europe Recombinant Carbonyl Reductase Sales by Country (2026-2031) & (K G)
Table 110. Europe Recombinant Carbonyl Reductase Revenue by Country (2020-2025) & (US$ Million)
Table 111. Europe Recombinant Carbonyl Reductase Revenue by Country (2026-2031) & (US$ Million)
Table 112. Asia Pacific Recombinant Carbonyl Reductase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 113. Asia Pacific Recombinant Carbonyl Reductase Sales by Country (2020-2025) & (K G)
Table 114. Asia Pacific Recombinant Carbonyl Reductase Sales by Country (2026-2031) & (K G)
Table 115. Asia Pacific Recombinant Carbonyl Reductase Revenue by Country (2020-2025) & (US$ Million)
Table 116. Asia Pacific Recombinant Carbonyl Reductase Revenue by Country (2026-2031) & (US$ Million)
Table 117. South America Recombinant Carbonyl Reductase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 118. South America Recombinant Carbonyl Reductase Sales by Country (2020-2025) & (K G)
Table 119. South America Recombinant Carbonyl Reductase Sales by Country (2026-2031) & (K G)
Table 120. South America Recombinant Carbonyl Reductase Revenue by Country (2020-2025) & (US$ Million)
Table 121. South America Recombinant Carbonyl Reductase Revenue by Country (2026-2031) & (US$ Million)
Table 122. Middle East and Africa Recombinant Carbonyl Reductase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 123. Middle East and Africa Recombinant Carbonyl Reductase Sales by Country (2020-2025) & (K G)
Table 124. Middle East and Africa Recombinant Carbonyl Reductase Sales by Country (2026-2031) & (K G)
Table 125. Middle East and Africa Recombinant Carbonyl Reductase Revenue by Country (2020-2025) & (US$ Million)
Table 126. Middle East and Africa Recombinant Carbonyl Reductase Revenue by Country (2026-2031) & (US$ Million)
Table 127. Global Recombinant Carbonyl Reductase Sales by Type (2020-2025) & (K G)
Table 128. Global Recombinant Carbonyl Reductase Sales by Type (2026-2031) & (K G)
Table 129. Global Recombinant Carbonyl Reductase Sales Market Share by Type (2020-2025)
Table 130. Global Recombinant Carbonyl Reductase Sales Market Share by Type (2026-2031)
Table 131. Global Recombinant Carbonyl Reductase Revenue by Type (2020-2025) & (US$ Million)
Table 132. Global Recombinant Carbonyl Reductase Revenue by Type (2026-2031) & (US$ Million)
Table 133. Global Recombinant Carbonyl Reductase Revenue Market Share by Type (2020-2025)
Table 134. Global Recombinant Carbonyl Reductase Revenue Market Share by Type (2026-2031)
Table 135. Global Recombinant Carbonyl Reductase Price by Type (2020-2025) & (US$/K G)
Table 136. Global Recombinant Carbonyl Reductase Price by Type (2026-2031) & (US$/K G)
Table 137. Global Recombinant Carbonyl Reductase Sales by Application (2020-2025) & (K G)
Table 138. Global Recombinant Carbonyl Reductase Sales by Application (2026-2031) & (K G)
Table 139. Global Recombinant Carbonyl Reductase Sales Market Share by Application (2020-2025)
Table 140. Global Recombinant Carbonyl Reductase Sales Market Share by Application (2026-2031)
Table 141. Global Recombinant Carbonyl Reductase Revenue by Application (2020-2025) & (US$ Million)
Table 142. Global Recombinant Carbonyl Reductase Revenue by Application (2026-2031) & (US$ Million)
Table 143. Global Recombinant Carbonyl Reductase Revenue Market Share by Application (2020-2025)
Table 144. Global Recombinant Carbonyl Reductase Revenue Market Share by Application (2026-2031)
Table 145. Global Recombinant Carbonyl Reductase Price by Application (2020-2025) & (US$/K G)
Table 146. Global Recombinant Carbonyl Reductase Price by Application (2026-2031) & (US$/K G)
Table 147. Key Raw Materials
Table 148. Raw Materials Key Suppliers
Table 149. Recombinant Carbonyl Reductase Distributors List
Table 150. Recombinant Carbonyl Reductase Customers List
Table 151. Recombinant Carbonyl Reductase Industry Trends
Table 152. Recombinant Carbonyl Reductase Industry Drivers
Table 153. Recombinant Carbonyl Reductase Industry Restraints
Table 154. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Recombinant Carbonyl Reductase Product Image
Figure 5. Global Recombinant Carbonyl Reductase Revenue (US$ Million), 2020 VS 2024 VS 2031
Figure 6. Global Recombinant Carbonyl Reductase Market Size (2020-2031) & (US$ Million)
Figure 7. Global Recombinant Carbonyl Reductase Sales (2020-2031) & (K G)
Figure 8. Global Recombinant Carbonyl Reductase Average Price (US$/K G) & (2020-2031)
Figure 9. Liquid Product Image
Figure 10. Powder Product Image
Figure 11. Pharmaceutical Synthesis Product Image
Figure 12. Chemical Manufacturing Product Image
Figure 13. Others Product Image
Figure 14. Global Recombinant Carbonyl Reductase Revenue Share by Manufacturers in 2024
Figure 15. Global Manufacturers of Recombinant Carbonyl Reductase, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Recombinant Carbonyl Reductase Players Market Share by Revenue in 2024
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 18. Global Recombinant Carbonyl Reductase Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 19. Global Recombinant Carbonyl Reductase Sales by Region in 2024
Figure 20. Global Recombinant Carbonyl Reductase Revenue by Region in 2024
Figure 21. North America Recombinant Carbonyl Reductase Market Size by Country in 2024
Figure 22. North America Recombinant Carbonyl Reductase Sales Market Share by Country (2020-2031)
Figure 23. North America Recombinant Carbonyl Reductase Revenue Market Share by Country (2020-2031)
Figure 24. United States Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Mexico Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Recombinant Carbonyl Reductase Market Size by Country in 2024
Figure 28. Europe Recombinant Carbonyl Reductase Sales Market Share by Country (2020-2031)
Figure 29. Europe Recombinant Carbonyl Reductase Revenue Market Share by Country (2020-2031)
Figure 30. Germany Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Spain Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Netherlands Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Switzerland Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Sweden Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Poland Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Asia Pacific Recombinant Carbonyl Reductase Market Size by Country in 2024
Figure 41. Asia Pacific Recombinant Carbonyl Reductase Sales Market Share by Country (2020-2031)
Figure 42. Asia Pacific Recombinant Carbonyl Reductase Revenue Market Share by Country (2020-2031)
Figure 43. China Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Japan Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. South Korea Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. India Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Australia Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Taiwan Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Southeast Asia Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Southeast Asia Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. South America Recombinant Carbonyl Reductase Market Size by Country in 2024
Figure 52. South America Recombinant Carbonyl Reductase Sales Market Share by Country (2020-2031)
Figure 53. South America Recombinant Carbonyl Reductase Revenue Market Share by Country (2020-2031)
Figure 54. Brazil Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Argentina Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Chile Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Recombinant Carbonyl Reductase Market Size by Country in 2024
Figure 58. Middle East and Africa Recombinant Carbonyl Reductase Sales Market Share by Country (2020-2031)
Figure 59. Middle East and Africa Recombinant Carbonyl Reductase Revenue Market Share by Country (2020-2031)
Figure 60. Egypt Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. South Africa Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Israel Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 63. Türkiye Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 64. GCC Countries Recombinant Carbonyl Reductase Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 65. Global Recombinant Carbonyl Reductase Sales Market Share by Type (2020-2031)
Figure 66. Global Recombinant Carbonyl Reductase Revenue Market Share by Type (2020-2031)
Figure 67. Global Recombinant Carbonyl Reductase Price (US$/K G) by Type (2020-2031)
Figure 68. Global Recombinant Carbonyl Reductase Sales Market Share by Application (2020-2031)
Figure 69. Global Recombinant Carbonyl Reductase Revenue Market Share by Application (2020-2031)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings